Latest Innovation News

Tetratherix Limited launches a new precision medicine franchise leveraging its Tetramatrix™ platform, securing a decade-long exclusive partnership with US health group Superpower Health Inc. This deal promises immediate revenue and complements ongoing FDA milestones.

EMVision Medical Devices has secured a $3.8 million R&D tax rebate and gained approval to claim rebates on overseas expenditures, strengthening its financial footing as it advances clinical trials for its neurodiagnostic device.

Vection Technologies has secured approximately $4 million in new orders for its Algho AI platform, spanning 10 diverse industry verticals and reinforcing its strong momentum following a record half-year performance.

Oneview Healthcare has successfully raised A$19 million through a two-tranche placement and launched a Security Purchase Plan to further strengthen its financial position and accelerate AI development.

Structural Monitoring Systems Plc has resolved its Federal Court proceedings with a settlement, allowing the company to refocus on its core business priorities.

iCandy Interactive is exploring a US listing for its subsidiary Lemon Sky Studios to unlock shareholder value, while facing a likely ASX delisting due to audit delays. The company also plans a capital raise to support these initiatives.

Aquirian Limited advances its Drillforce subsidiary with new technology and equipment while mutually ending a planned joint venture with Topgroup, who remains a strategic shareholder.

EVE Health Group has raised $0.9 million to advance its pharmaceutical reformulation programs targeting global markets worth over US$30 billion. The funding will support development of improved delivery technologies for medicines nearing patent expiry.

Acrux Limited has secured a $0.55 million advance on its FY26 R&D Tax Incentive, providing crucial funding to accelerate development of its Hormone Replacement Therapy following FDA regulatory confirmation.

Osteopore Limited has secured non-exclusive distribution rights for an injectable regenerative bone filler across Southeast Asia, marking a strategic expansion of its orthopaedic product portfolio and opening new revenue channels.

InteliCare has secured its largest contract yet, signing a five-year $8.8 million agreement with Victorian aged care provider mecwacare to deploy its AI-driven platform across 22 residential facilities.

OMG Group has launched two new matcha brands targeting both premium and mass-market consumers, supported by a five-year exclusive supply agreement for ceremonial-grade Japanese matcha. This move positions OMG to capitalise on the booming global matcha market through a vertically integrated strategy.